shRNAs Targeting a Common <i>KCNQ1</i> Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele
Long-QT syndrome type 1 (LQT1) is caused by mutations in <i>KCNQ1</i>. Patients heterozygous for such a mutation co-assemble both mutant and wild-type <i>KCNQ1</i>-encoded subunits into tetrameric Kv7.1 potassium channels. Here, we investigated whether allele-specific inhibit...
Main Authors: | Lucía Cócera-Ortega, Ronald Wilders, Selina C. Kamps, Benedetta Fabrizi, Irit Huber, Ingeborg van der Made, Anouk van den Bout, Dylan K. de Vries, Lior Gepstein, Arie O. Verkerk, Yigal M. Pinto, Anke J. Tijsen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/7/4053 |
Similar Items
-
Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Yongfei Song, et al.
Published: (2022-05-01) -
Metabolic Behaviors of Aconitum Alkaloids in Different Concentrations of <i>Aconiti Lateralis Radix Praeparata</i> and Effects of Aconitine in Healthy Human and Long QT Syndrome Cardiomyocytes
by: Liang Yang, et al.
Published: (2022-06-01) -
Deciphering DSC2 arrhythmogenic cardiomyopathy electrical instability: From ion channels to ECG and tailored drug therapy
by: Adrien Moreau, et al.
Published: (2021-03-01) -
Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates
by: Suzan J. G. Knottnerus, et al.
Published: (2020-04-01) -
Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
by: Augustine, George James, et al.
Published: (2017)